Buy Wegovy online in australia from Onlinepharmaustralia. Wegovy is a prescription medicine containing semaglutide that is administered once a week. For eligible adults using Wegovy for chronic weight management, treatment follows a gradual dosing schedule that starts at a low dose and increases over time before reaching the usual maintenance dose.
Understanding the Wegovy treatment schedule can help patients know what to expect during the first several months of treatment, including when doses normally increase, why escalation is gradual, what happens if side effects occur and how missed doses are managed.
In Australia, Wegovy is a Schedule 4 prescription medicine and is used for approved indications under medical supervision.
What Is the Wegovy Treatment Schedule?
The Wegovy treatment schedule is the planned progression from the starting dose to the maintenance dose.
For the standard adult weight-management schedule, the Australian Product Information describes:
| Treatment period | Wegovy dose |
|---|---|
| Weeks 1–4 | 0.25 mg once weekly |
| Weeks 5–8 | 0.5 mg once weekly |
| Weeks 9–12 | 1 mg once weekly |
| Weeks 13–16 | 1.7 mg once weekly |
| Maintenance | 2.4 mg once weekly |
The maintenance dose of 2.4 mg once weekly is reached gradually over a 16-week escalation period.
This is the standard dosing framework and should not be interpreted as an individualized prescription.
Why Does Wegovy Treatment Start at a Low Dose?
Wegovy does not normally begin at the maintenance dose.
Treatment starts at 0.25 mg once weekly, followed by gradual increases.
The purpose of the gradual escalation is to reduce the likelihood of gastrointestinal symptoms and allow the body to adjust to semaglutide.
Possible gastrointestinal effects include:
- Nausea
- Vomiting
- Diarrhoea
- Constipation
- Abdominal discomfort
- Indigestion
If significant gastrointestinal symptoms occur, the Australian Product Information states that dose escalation can be delayed until symptoms improve.
Wegovy Treatment Schedule: Weeks 1–4
0.25 mg Once Weekly
The first four weeks generally involve a 0.25 mg injection once a week.
This is the starting phase of treatment.
The purpose is not to reach the maintenance dose immediately. Instead, the initial dose allows treatment to begin gradually.
Patients should follow the dose prescribed by their healthcare professional rather than increasing the dose based on how quickly they want results.
Wegovy Treatment Schedule: Weeks 5–8
0.5 mg Once Weekly
During weeks 5 through 8, the standard schedule increases to 0.5 mg once weekly.
The increase should occur according to the treatment plan provided by your prescriber.
If you are experiencing significant gastrointestinal symptoms, speak with your healthcare professional before increasing the dose.
Wegovy Treatment Schedule: Weeks 9–12
1 mg Once Weekly
The standard schedule then progresses to 1 mg once weekly during weeks 9 through 12.
At this stage, your healthcare professional may continue to assess how well you tolerate the treatment.
The dose should not be increased more quickly than prescribed.
Wegovy Treatment Schedule: Weeks 13–16
1.7 mg Once Weekly
During weeks 13 through 16, the standard schedule progresses to 1.7 mg once weekly.
This is the final standard escalation stage before the usual adult maintenance dose.
If significant gastrointestinal symptoms develop, dose escalation may be delayed.
Wegovy Maintenance Treatment
2.4 mg Once Weekly
After the initial escalation period, the usual adult maintenance dose is 2.4 mg once weekly.
The maintenance phase is intended for ongoing treatment rather than simply a short final stage.
Wegovy is approved in Australia for chronic weight management, including weight loss and weight maintenance, in eligible adults.
How long an individual remains on treatment depends on their circumstances and ongoing clinical assessment.
Can the Wegovy Treatment Schedule Be Adjusted?
Yes.
The standard schedule provides a framework, but a healthcare professional may adjust treatment when clinically appropriate.
For example, if significant gastrointestinal symptoms occur, the TGA Product Information states that dose escalation should be considered for delay until symptoms improve.
If a patient does not tolerate the 2.4 mg dose, the dose can temporarily be reduced to 1.7 mg once weekly, with re-escalation to the recommended maintenance dose considered later.
Patients should not independently change their Wegovy dose.
Does Everyone Follow the Same Wegovy Schedule?
The standard schedule is the same general framework, but individual treatment can differ.
A healthcare professional may consider factors such as:
- Treatment response
- Gastrointestinal symptoms
- Other medicines
- Existing health conditions
- Previous treatment history
- Tolerance of dose increases
- Individual treatment goals
Therefore, the calendar should not replace medical advice.
A patient who needs a slower escalation should follow the plan provided by their prescriber.
What Day of the Week Should You Take Wegovy?
Wegovy is administered once weekly.
It can be administered at any time of day, with or without meals.
There is no universal requirement to use Monday, Friday or another particular day.
Many patients find it easier to select one consistent day and build the injection into their weekly routine.
Can You Change Your Wegovy Treatment Day?
The weekly administration day can be changed when necessary.
The Australian Product Information states that there should be at least 72 hours between two doses when changing the day of administration. Once the new day is selected, once-weekly dosing should continue.
If you are unsure how to change your treatment day, ask your doctor or pharmacist.
What Happens If You Miss a Wegovy Dose?
The Australian Product Information provides specific instructions for missed doses.
Missed dose within 5 days
Take the missed dose as soon as possible.
More than 5 days since the missed dose
Skip the missed dose and take the next injection on your normal scheduled day.
Afterward, continue the regular once-weekly schedule.
If several doses are missed, your healthcare professional may consider whether restarting at a lower dose is appropriate.
Do not take two doses close together to compensate for a missed injection.
Can You Increase Wegovy Faster to Get Results Sooner?
No.
The standard treatment schedule is deliberately gradual.
Increasing the dose earlier than prescribed may increase the risk of adverse effects, particularly gastrointestinal symptoms.
The Australian Product Information specifies a 16-week escalation period to reach the 2.4 mg maintenance dose.
A faster schedule should not be used unless specifically directed by an appropriately qualified healthcare professional.
What Happens During Wegovy Treatment?
Wegovy treatment is more than simply following a dose calendar.
During treatment, your healthcare professional may monitor:
- Body weight
- Treatment response
- Side effects
- Dose tolerance
- Existing medical conditions
- Other medicines
- Dietary habits
- Physical activity
- Long-term treatment goals
This monitoring can help determine whether the current treatment plan remains appropriate.
Wegovy Treatment and Weight Management
For its approved adult weight-management indication, Wegovy is used alongside a reduced-energy diet and increased physical activity.
The medicine should therefore be viewed as one component of a broader weight-management plan.
Individual responses vary, and the amount or rate of weight change cannot be predicted for a particular person solely from the dosing schedule.
How Long Does the Wegovy Treatment Schedule Last?
The initial dose-escalation period lasts approximately 16 weeks under the standard schedule.
After that, eligible patients who continue treatment generally enter the maintenance phase.
There is no single treatment duration that applies to everyone.
Wegovy is indicated for chronic weight management, including weight maintenance, so treatment may continue when a healthcare professional determines that ongoing treatment is appropriate.
Wegovy Treatment Schedule and Side Effects
Side effects can occur at different stages of treatment.
Gastrointestinal effects are particularly relevant when doses are increased.
Commonly reported symptoms include:
- Nausea
- Vomiting
- Diarrhoea
- Constipation
- Abdominal discomfort
Significant or persistent symptoms should be discussed with your healthcare professional.
The TGA Product Information specifically allows dose escalation to be delayed when significant gastrointestinal symptoms occur.
What If 2.4 mg Is Not Tolerated?
The usual adult maintenance dose is 2.4 mg once weekly.
However, if this dose is not tolerated, the Australian Product Information allows the dose to be temporarily reduced to 1.7 mg once weekly. Re-escalation to 2.4 mg can then be considered.
This adjustment should be made under medical supervision.
Do not switch between Wegovy strengths without discussing the change with your prescriber.
Wegovy Treatment Schedule and Injection Sites
Wegovy is administered by subcutaneous injection.
The Australian Product Information identifies the:
- Abdomen
- Thigh
- Upper arm
as injection sites. The injection site can be changed without changing the dose. Wegovy should not be administered intravenously or intramuscularly.
Patients should follow the instructions supplied with their specific Wegovy device.
Wegovy Treatment Schedule and Storage
Proper storage is important throughout treatment.
Healthdirect currently states that Wegovy should be:
- Refrigerated at 2°C to 8°C
- Protected from light
- Not frozen
Always check the current Consumer Medicine Information supplied with your product because storage instructions can depend on the specific presentation.
If you believe your medicine has been frozen or stored incorrectly, speak with a pharmacist before using it.
Who May Receive Wegovy Treatment in Australia?
For chronic weight management in adults, the Australian indication includes people with an initial BMI of:
- 30 kg/m² or higher, or
- 27 kg/m² to less than 30 kg/m² with at least one weight-related comorbidity.
Wegovy is used alongside a reduced-energy diet and increased physical activity.
Meeting a BMI threshold does not automatically mean that Wegovy is appropriate for an individual.
A healthcare professional needs to consider the person’s broader medical circumstances before prescribing.
Wegovy also has separate approved indications for certain adolescents and for specific cardiovascular and liver conditions, each with its own eligibility requirements.
Is Wegovy a Prescription Medicine in Australia?
Yes.
Healthdirect currently lists Wegovy as a Schedule 4 prescription-only medicine. It is supplied through a pharmacist when appropriately prescribed.
This means patients should not obtain Wegovy through websites claiming to provide prescription-only treatment without appropriate medical oversight.
A legitimate treatment pathway should include appropriate clinical assessment and prescription.
Wegovy Treatment Schedule vs Wegovy Injection Schedule
These terms are related but have slightly different search intent.
Wegovy injection schedule generally focuses on when and how often injections are administered.
Wegovy treatment schedule is broader. It covers:
- Starting treatment
- Dose escalation
- Maintenance
- Dose adjustments
- Missed doses
- Ongoing monitoring
- Long-term treatment
This makes the treatment schedule a useful overview for someone who is considering or beginning Wegovy.
Wegovy Treatment Schedule: A Simple Overview
The standard adult schedule can be summarized as:
Month 1:
0.25 mg once weekly
2:
0.5 mg once weekly
3:
1 mg once weekly
4:
1.7 mg once weekly
Maintenance:
2.4 mg once weekly
This is the standard Australian dosing framework. Individual patients may require adjustments depending on tolerability and clinical circumstances.
Frequently Asked Questions About the Wegovy Treatment Schedule
How long is the Wegovy treatment schedule?
The standard dose-escalation period lasts 16 weeks, followed by the maintenance phase.
What is the starting dose of Wegovy?
The standard starting dose is 0.25 mg once weekly.
When does Wegovy reach the maintenance dose?
Under the standard schedule, the maintenance dose is reached after the 16-week escalation period.
What is the usual maintenance dose of Wegovy?
For the standard adult weight-management schedule, it is 2.4 mg once weekly.
Can Wegovy dose escalation be delayed?
Yes. If significant gastrointestinal symptoms occur, the Australian Product Information states that dose escalation can be delayed until symptoms improve.
Can I stay on 1.7 mg Wegovy?
If 2.4 mg is not tolerated, the dose may temporarily be reduced to 1.7 mg, with re-escalation considered later. This should be managed by a healthcare professional.
What happens if I miss a Wegovy injection?
Take the missed dose within 5 days when possible. If more than 5 days have passed, skip it and take the next dose on the regular day.
Can I change my Wegovy injection day?
Yes. There should be at least 72 hours between two doses when changing the weekly administration day.
Can I take Wegovy with food?
Yes. Wegovy can be administered at any time of day, with or without meals.
Does everyone need the same Wegovy treatment schedule?
The standard schedule provides the general framework, but treatment may be adjusted according to individual tolerability and medical circumstances.
Do I need a prescription for Wegovy in Australia?
Yes. Wegovy is a Schedule 4 prescription-only medicine in Australia.
Final Thoughts
The Wegovy treatment schedule is designed to introduce semaglutide gradually and then maintain treatment at the usual adult dose.
The standard Australian schedule begins at 0.25 mg once weekly, increases every four weeks through 0.5 mg, 1 mg and 1.7 mg, and then reaches the usual 2.4 mg once-weekly maintenance dose.
However, the standard calendar is not a substitute for individualized medical care. Dose escalation may need to be delayed when significant gastrointestinal symptoms occur, and the maintenance dose can be adjusted when it is not tolerated.
If you are considering Wegovy or have recently started treatment, discuss your individual treatment schedule with your doctor or pharmacist and follow the current Australian Product Information supplied with your medicine.
Medical Information Notice: This article is for general educational purposes and does not replace individual medical advice, diagnosis or treatment. Wegovy is a prescription medicine. Always follow your prescriber’s instructions and the current Australian Product Information and Consumer Medicine Information. Medicine information can be updated as new evidence and safety information become available.
Authoritative Australian Sources
- Therapeutic Goods Administration (TGA) — Wegovy Product Information and Australian registration information.
- Healthdirect Australia — Wegovy medicine information, indications, storage and prescription status.